Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market by Size | Growth | Analysis | Trends and Forecasts to 2027 - CMI

 


Overview

Human immunoglobulin is a sterile human plasma solution. Diseases such as primary immunodeficiency are managed by intravenous injection of human immunoglobulin (IGIV). Human immunoglobulin also helps to increase platelets (blood clotting cells) in people with immune thrombocytopenic purpura and prevents infection in people with B-cell chronic lymphocytic leukaemia. Patients with Kawasaki syndrome are administered human immunoglobulin to avoid aneurysm caused by the narrowing of the main artery in the heart. 


In addition, intravenous human immunoglobulin (pH4) is being extensively researched to improve COVID-19 therapy. This is likely to boost demand for human immunoglobulin (pH4) for intravenous injection and boost the growth of the global human immunoglobulin (ph4) for intravenous injection (COVID-19)  market during the forecast years.


The global demand for human immunoglobulin (pH4) for intravenous injection (COVID-19) market is projected to be US$ 43,205.84 million in 2020 and is anticipated to have a CAGR of 12.7% over the forecast years (2020-2027).


Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Restraint


Side effects such as headache, cough, fatigue, infusion site reactions, nausea, hives, sinusitis, high blood pressure, diarrhoea, dizziness, and lethargy associated with human immunoglobulin (pH4) for intravenous injection are expected to impede market development. For example, on July 2017, Octapharma USA Inc. issued a voluntary market withdrawal of Octagam, a human immune globulin intravenous fluid, as a result of increased hypersensitivity events such as hives, wheezing and anaphylactoid-type reactions.

For More Information, Click Here:  https://www.globenewswire.com/news-release/2020/04/23/2021131/0/en/Global-Human-Immunoglobulin-pH4-for-Intravenous-Injection-COVID-19-Market-to-Surpass-US-99-772-2-Million-by-2027-CMI.html

Comments

Popular posts from this blog

Canada Nano-Enabled Packaging For Food And Beverage Is Witnessing Massive Demand Due To Reduction In Waste And Cost-Saving

Global Biofeedback Measurement Instrument Market to Rise During the COVID-19 Crisis Period Owing to Increasing Consumer Awareness

Global Automotive Pumps Market is expected to be valued at US$ 67214.51 Mn by end of 2027, Says CMI